Maleic Acid

Maleic Acid

SCHEMBL2883980

CS(N)(=O)=O.O=C(O)/C=C\C(=O)O

nearest known ligand 0.56

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2BTKCACNA1CCACNA1DCACNA1FCACNA1SCCR5CPT1BCPT2DPP4DRD1DRD2EGFRERBB2ERBB4HRH1HRH3HTR1AHTR2AHTR2BHTR2CHTR4JAK1JAK2JAK3MPLMTORPPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PPARGSLC6A2SLC6A3SLC6A4SMOTYK2pol

The experimentally established mechanism targets of Maleic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 4/20 0.56
TP53 P04637 1/20 0.56
EGLN1 Q9GZT9 1/20 0.56
EGLN3 Q9H6Z9 1/20 0.56
CA1 P00915 1/20 0.50
HCAR2 Q8TDS4 4/20 0.43
GABRP O00591 2/20 0.42
GABRD O14764 2/20 0.42
GABRA1 P14867 2/20 0.42
GABRB1 P18505 2/20 0.42
GABRG2 P18507 2/20 0.42
GABRB3 P28472 2/20 0.42
GABRA5 P31644 2/20 0.42
GABRA3 P34903 2/20 0.42
GABRA2 P47869 2/20 0.42
GABRB2 P47870 2/20 0.42
GABRA4 P48169 2/20 0.42
GABRE P78334 2/20 0.42
GABRA6 Q16445 2/20 0.42
GABRG1 Q8N1C3 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Fumaric Acid SCHEMBL930728 1.00 TSHR (0.56) TSHRTP53EGLN1EGLN3CA1
Fumaric Acid SCHEMBL930726 1.00 TSHR (0.56) TSHRTP53EGLN1EGLN3CA1
Maleic Acid SCHEMBL8979615 0.84 TSHR (0.60) TSHRTP53EGLN1EGLN3CA1
Fumaric Acid SCHEMBL3176640 0.84 TSHR (0.60) TSHRTP53EGLN1EGLN3HCAR2
Maleic Acid SCHEMBL3176628 0.84 TSHR (0.60) TSHRTP53EGLN1EGLN3HCAR2
Fumaric Acid SCHEMBL27710817 0.84 TSHR (0.60) TSHRTP53EGLN1EGLN3HCAR2
Maleic Acid SCHEMBL27744562 0.82 TSHR (0.50) TSHRTP53EGLN1EGLN3HCAR2
Maleic Acid SCHEMBL28807726 0.81 TSHR (0.56) TSHRTP53EGLN1EGLN3HCAR2
Fumaric Acid SCHEMBL930450 0.80 TSHR (0.47) TSHRTP53EGLN1EGLN3HCAR2
Fumaric Acid SCHEMBL930451 0.80 TSHR (0.47) TSHRTP53EGLN1EGLN3HCAR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1718629-B1 Benzopyran compounds useful for the treatment of arrhytmia NISSAN CHEMICAL IND LTD (JP) 2012-12-26 EP claimed
US-7781483-B2 Benzopyran compound NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2010-08-24 US claimed
EP-1718629-A2 BENZOPYRAN COMPOUNDS USEFUL FOR THE TREATMENT OF ARRHYTMIA Nissan Chemical Industries, Ltd. (JP) 2006-11-08 EP claimed
WO-2005080368-A2 BENZOPYRAN COMPOUND USEFUL FOR THE TREATMENT OF ARRHYTMIA NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2005-09-01 WO claimed
EP-2874630-B1 DOSING REGIMEN FOR JANUS KINASE (JAK) INHIBITORS ZOETIS SERVICES LLC (US) 2018-12-05 EP disclosed
CN-108354938-A JANUS kinases(JAK)The dosage regimen of inhibitor 硕腾服务有限责任公司 2018-08-03 CN disclosed
EP-1718629-B1 Benzopyran compounds useful for the treatment of arrhytmia NISSAN CHEMICAL IND LTD (JP) 2012-12-26 EP disclosed
EP-1718629-A2 BENZOPYRAN COMPOUNDS USEFUL FOR THE TREATMENT OF ARRHYTMIA Nissan Chemical Industries, Ltd. (JP) 2006-11-08 EP disclosed
WO-2005080368-A2 BENZOPYRAN COMPOUND USEFUL FOR THE TREATMENT OF ARRHYTMIA NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2005-09-01 WO disclosed